IDEAS home Printed from https://ideas.repec.org/a/pal/gpprii/v28y2003i2p316-330.html
   My bibliography  Save this article

Pharmacogenetics: A New – or not so New?—Concept in Healthcare

Author

Listed:
  • Klaus Lindpaintner

    (Roche Genetics and Roche Center for Medical Genomics, Basel, Switzerland)

Abstract

Pharmacogenetics is today widely proclaimed as being about to revolutionize the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will continue to provide us, as it has done already, with better ways to diagnose and treat illnesses, but it will do so at a stepwise and evolutionary pace, based on an improved understanding of the nature of disease, allowing more specific treatments, better risk prediction, and the implementation of preventive strategies. As such, future progress in biomedicine will travel the same well-trodden paths of improved differential diagnosis and risk prediction along which it has advanced for the last decades and centuries. So, while meaningful biomedical research today, by and large, depends on the use of the newly developed tools of genetics and genomics, and the insights we gain through them, it is unlikely to fundamentally change the direction of medical progress. The Geneva Papers on Risk and Insurance (2003) 28, 316–330. doi:10.1111/1468-0440.00226

Suggested Citation

  • Klaus Lindpaintner, 2003. "Pharmacogenetics: A New – or not so New?—Concept in Healthcare," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 28(2), pages 316-330, April.
    • Handle: RePEc:pal:gpprii:v:28:y:2003:i:2:p:316-330
    as

    Download full text from publisher

    File URL: http://www.palgrave-journals.com/gpp/journal/v28/n2/pdf/2500226a.pdf
    File Function: Link to full text PDF
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: http://www.palgrave-journals.com/gpp/journal/v28/n2/full/2500226a.html
    File Function: Link to full text HTML
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:gpprii:v:28:y:2003:i:2:p:316-330. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave-journals.com/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.